Loading...
Loading...
GlaxoSmithKline has stuck a deal to buy US-listed biopharmaceutical Nuvalent for just over $10.6 billion.
Old Adam "The Nighthawk" McNestrie of the Insurance Insider has just come up with a decent new line on the Hiscox takeover tale.
Barry Diller’s People Inc. has offered to buy US-listed casino giant for around $12.4 billion.
Today's fresh deal in the London market is Drax's acquisition of London-listed renewable energy investment trust Bluefield Solar Income.
Oliver "An Englishman in New York" Barnes is on a bit of a hot streak at the moment.
Dealmania continues into the weekend.
The Insurance Post has delivered a decent scoop this morning about a takeover of Lloyd's of London insurer Hiscox.
You don't often find deal stories in The Times stock tipping column Tempus.
Italian FT journalist Silvia Sciorilli Borrelli has landed a giant deal scoop this evening.
Here is a little extra snippet on the Teleflex takeover situation that little old Betaville first revealed last Friday in an UNCOOKED alert.
I see arch rivals at Bloomberg and Reuters have followed up little old Betaville's UNCOOKED Alert about the takeover rumours surrounding US-listed medical devices maker Teleflex Inc.
Here is a rare thing: a takeover tale from French publication La Lettre that hasn't appeared in these pixels before.
Quelle surprise: La Lettre has today followed up another UNCOOKED Alert from little old Betaville.
A corporate mouthpiece for Abivax has denied La Lettre's latest instalment on the French company's takeover saga.
920p a share.
There were more signs of a rekindling of dealmaking activity in the biopharmaceutical industry this morning.
Little old Betaville was last week pondering on whether the dealmaking boom in the biotechnology industry had cooled off entirely as there hadn't been any multi-billion dollar deals announced for several few weeks.
More from the Twitterati on the Eli Lilly private jet that landed earlier this week in Paris.